neratinib

Italy

Drugs containing this active substance

  • NERLYNX

    It is used for the treatment of early-stage breast cancer in patients who are hormone receptor-positive (HR-positive) and HER2 receptor-positive (HER2-positive), and who have already received treatment with trastuzumab.

    Form: tablets, film-coated

    Active substance Dosage
    neratinib -

    ATC: L01EH02

    Manufacturer: PIERRE FABRE MEDICAMENT